Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel ...

Higher intake of legumes and soy products is associated with fewer chronic obstructive pulmonary disease (COPD) symptoms ...

Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD continuing as planned based on independent DMC review of ...

Nebuliser use in COPD is most common in severe disease with frequent exacerbations, high symptoms, and reduced lung function.

Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD continuing as planned based on independent DMC review of pre-specified interim analysis - - Expect to report topline data ...

KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late ...

FDA approves Breztri Aerosphere for asthma, introducing the first single-inhaler triple-combination maintenance therapy for patients aged 12 and older. FDA approved Breztri Aerosphere ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a broad body of ...

Doe and colleagues assessed an AI software’s ability to improve spirometry interpretation performance by primary care ...

Background Cardiovascular disease and osteoarthritis (OA) share risk factors, but the link between comprehensive ...

A recent study conducted by researchers at the University of Cape Town’s (UCT) School of Public Health has provided new insights into the long-term health consequences and mortality experience of ...